Esperion Therapeutics, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q1 2019 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
Esperion Therapeutics, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q1 2019 to Q2 2024.
  • Esperion Therapeutics, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $6.85M, a 184% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $6.85M +$4.44M +184% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 $7.13M +$6.06M +563% Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $4.68M +$3.64M +351% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 $3.02M +$2.29M +313% Sep 30, 2023 10-Q 2023-11-07
Q2 2023 $2.41M +$1.33M +122% Jun 30, 2023 10-Q 2023-08-01
Q1 2023 $1.08M -$392K -26.7% Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $1.04M -$862K -45.4% Dec 31, 2022 10-K 2024-02-27
Q3 2022 $730K -$2.99M -80.4% Sep 30, 2022 10-Q 2022-11-01
Q2 2022 $1.09M -$3.18M -74.5% Jun 30, 2022 10-Q 2022-08-02
Q1 2022 $1.47M -$3.39M -69.8% Mar 31, 2022 10-Q 2022-05-03
Q4 2021 $1.9M -$4.13M -68.5% Dec 31, 2021 10-K 2023-02-21
Q3 2021 $3.72M -$2.99M -44.6% Sep 30, 2021 10-Q 2021-11-02
Q2 2021 $4.26M -$1.91M -31% Jun 30, 2021 10-Q 2021-08-03
Q1 2021 $4.85M -$658K -11.9% Mar 31, 2021 10-Q 2021-05-04
Q4 2020 $6.03M +$4.5M +294% Dec 31, 2020 10-K 2022-02-22
Q3 2020 $6.7M +$5.65M +535% Sep 30, 2020 10-Q 2020-11-02
Q2 2020 $6.18M +$5.24M +563% Jun 30, 2020 10-Q 2020-08-10
Q1 2020 $5.51M +$4.56M +479% Mar 31, 2020 10-Q 2020-05-06
Q4 2019 $1.53M Dec 31, 2019 10-K 2021-02-23
Q3 2019 $1.06M Sep 30, 2019 10-Q 2019-11-06
Q2 2019 $932K Jun 30, 2019 10-Q 2019-08-08
Q1 2019 $951K Mar 31, 2019 10-Q 2019-05-08
* An asterisk sign (*) next to the value indicates that the value is likely invalid.